ALK-Abello, Fornix BioSciences N.V. deal

ALK-Abello disclosed in its 2Q10 earnings that on July 1, it completed its previously announced acquisition of Fornix's Dutch allergy division, Artu Biologicals B.V., for DKK146 million ($25 million) ...